A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Public ClinicalTrials.gov record NCT06817356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Study identification
- NCT ID
- NCT06817356
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Mazdutide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
- Last update posted
- Mar 26, 2026
2025 – 2026
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Headlands Research - Scottsdale | Scottsdale | Arizona | 85260 | — |
| Woodland Resarch Northwest/ERG | Rogers | Arkansas | 72758 | — |
| Ark Clinical Research - Fountain Valley | Fountain Valley | California | 92708 | — |
| Synergy San Diego | Lemon Grove | California | 91945 | — |
| Headlands Research-Artemis San Diego | San Diego | California | 92123 | — |
| Research Centers of America ( Hollywood ) | Hollywood | Florida | 33024 | — |
| K2 Medical Research - Maitland | Maitland | Florida | 32751 | — |
| K2 Medical Research | Maitland | Florida | 32751 | — |
| Clinical Neuroscience Solutions Inc | Orlando | Florida | 32801 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| K2 Medical Research - Tampa | Tampa | Florida | 33634 | — |
| CenExel iResearch, LLC (CenExel iRA) | Decatur | Georgia | 30030 | — |
| DelRicht Research | Mandeville | Louisiana | 70471 | — |
| Adams Clinical | Watertown | Massachusetts | 02472 | — |
| Vitalix Clinical | Worcester | Massachusetts | 01608 | — |
| Redbird Research LLC | Las Vegas | Nevada | 89119 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10314 | — |
| Ichor Research | Syracuse | New York | 13210 | — |
| Davis Clinical | The Bronx | New York | 10461 | — |
| Summit Headlands | Portland | Oregon | 97210 | — |
| Rhode Island Mood & Memory Research Institute | East Providence | Rhode Island | 02914 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Clinical Neuroscience Solutions Inc | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials of Dallas | Dallas | Texas | 75251 | — |
| Dallas Clinical Research Center/Pillar Research | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06817356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06817356 live on ClinicalTrials.gov.